Advanced Medical Isotope Corporation (OTCMKTS:RDGL) Short Interest Update

Advanced Medical Isotope Corporation (OTCMKTS:RDGL) was the recipient of a significant decrease in short interest in the month of June. As of June 30th, there was short interest totaling 142,100 shares, a decrease of 65.1% from the June 15th total of 407,416 shares. Based on an average daily trading volume, of 2,234,493 shares, the days-to-cover ratio is currently 0.1 days. Currently, 0.0% of the company’s shares are sold short.

Advanced Medical Isotope Stock Down 3.7%

RDGL traded down $0.00 during trading hours on Tuesday, reaching $0.06. 2,484,659 shares of the company’s stock traded hands, compared to its average volume of 1,208,150. The firm has a 50-day moving average price of $0.07 and a 200 day moving average price of $0.07. Advanced Medical Isotope has a 52-week low of $0.04 and a 52-week high of $0.15. The firm has a market capitalization of $28.06 million, a PE ratio of -5.68 and a beta of -0.75.

Advanced Medical Isotope Company Profile

Vivos Inc, a radiation oncology medical device company, develops brachytherapy devices for the treatment of non-resectable tumors in the United States. It develops yttrium-90 based RadioGel device, an injectable particle-gel for brachytherapy radiation treatment of cancerous tumors in people and animals; and IsoPet for the treatment of solid tumors in animals. The company was formerly known as Advanced Medical Isotope Corporation and changed its name to Vivos Inc in December 2017. Vivos Inc was incorporated in 1994 and is headquartered in Richland, Washington.